Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16780 | 28181781 | Minerva Endocrinol | Thyroid dysfunction and non-alcoholic fatty liver disease. | 2017 | Details |
| A16781 | 28180059 | Mol Metab | JNK at the crossroad of obesity, insulin resistance, and cell stress response. | 2016 | Details |
| A16784 | 28178565 | Cell Metab | Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. | 2017 | Details |
| A16785 | 28178440 | Rambam Maimonides Med J | Comorbidities in Patients with Psoriatic Arthritis. | 2017 | Details |
| A16790 | 28176415 | Pediatr Diabetes | Visceral fat is associated with the racial differences in liver fat between black and white adolescent boys with obesity. | 2017 | Details |
| A16792 | 28174796 | Rom J Morphol Embryol | Non-alcoholic fatty liver disease - clinical and histopathological aspects. | 2016 | Details |
| A16794 | 28169509 | Obesity (Silver Spring) | Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study. | 2017 | Details |
| A16804 | 28163820 | Oxid Med Cell Longev | Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death. | 2017 | Details |
| A16805 | 28163011 | Obes Res Clin Pract | Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice. | 2017 | Details |
| A16807 | 28161992 | Am J Chin Med | Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling. | 2017 | Details |
| A16811 | 28159867 | J Lipid Res | Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase. | 2017 | Details |
| A16816 | 28155627 | Curr Vasc Pharmacol | Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity. | 2017 | Details |
| A16821 | 28152105 | PLoS One | Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. | 2017 | Details |
| A16826 | 28144390 | World J Hepatol | Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. | 2017 | Details |
| A16827 | 28144388 | World J Hepatol | Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. | 2017 | Details |
| A16828 | 28144387 | World J Hepatol | From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease. | 2017 | Details |
| A16833 | 28139281 | Clin Nutr | Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. | 2017 | Details |
| A16836 | 28138103 | Clin Sci (Lond) | Turning up the heat against metabolic syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
| A16838 | 28134687 | Curr Opin Gastroenterol | Fecal microbiota transplantation for gastrointestinal disorders. | 2017 | Details |
| A16848 | 28128316 | Sci Rep | Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013. | 2017 | Details |
| A16852 | 28126503 | Presse Med | [Pathophysiology of obstructive sleep apnea syndrome and its cardiometabolic consequences]. | 2017 | Details |
| A16857 | 28124507 | Obesity (Silver Spring) | Fatty liver promotes fibrosis in monkeys consuming high fructose. | 2017 | Details |
| A16861 | 28123944 | Mol Metab | Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. | 2016 | Details |
| A16862 | 28123936 | Mol Metab | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. | 2016 | Details |
| A16866 | 28120721 | Curr Pharm Des | Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension. | 2017 | Details |
| A16867 | 28120165 | J Inherit Metab Dis | Investigating the link of ACAD10 deficiency to type 2 diabetes mellitus. | 2017 | Details |
| A16868 | 28119530 | Int J Obes (Lond) | Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. | 2017 | Details |
| A16870 | 28116873 | Endocrinol Metab (Seoul) | The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis. | 2017 | Details |
| A16872 | 28116779 | Mol Nutr Food Res | Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity. | 2017 | Details |
| A16875 | 28115795 | Mediators Inflamm | The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. | 2017 | Details |
| A16876 | 28115523 | J Biol Chem | APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. | 2017 | Details |
| A16882 | 28112071 | J Dev Orig Health Dis | Early life programming and the risk of non-alcoholic fatty liver disease. | 2017 | Details |
| A16884 | 28111263 | Pharmacol Res | An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. | 2017 | Details |
| A16886 | 28110193 | Biomed Pharmacother | Effects of polyphenol compounds melanin on NAFLD/NASH prevention. | 2017 | Details |
| A16889 | 28109166 | Br J Pharmacol | A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference. | 2017 | Details |
| A16893 | 28108035 | Vet Clin North Am Small Anim Pract | Feline Hepatic Lipidosis. | 2017 | Details |
| A16894 | 28107471 | PLoS One | High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments. | 2017 | Details |
| A16898 | 28105511 | Calcif Tissue Int | Bone Density in the Obese Child: Clinical Considerations and Diagnostic Challenges. | 2017 | Details |
| A16903 | 28103626 | Hepatology | Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. | 2017 | Details |
| A16904 | 28101773 | World J Pediatr | What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children? | 2017 | Details |
| A16908 | 28099601 | An Bras Dermatol | Psoriasis comorbidities: complications and benefits of immunobiological treatment. | 2017 | Details |
| A16919 | 28092182 | Exp Biol Med (Maywood) | An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors. | 2017 | Details |
| A16927 | 28089433 | Surg Obes Relat Dis | Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity. | 2016 | Details |
| A16932 | 28088461 | Gastroenterology | Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. | 2017 | Details |
| A16933 | 28086768 | BMC Complement Altern Med | Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. | 2017 | Details |
| A16935 | 28084795 | Appl Physiol Nutr Metab | Moderate physical activity promotes basal hepatic autophagy in diet-induced obese mice. | 2016 | Details |
| A16943 | 28081779 | Metabolism | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. | 2016 | Details |
| A16947 | 28078997 | Curr Med Chem | Lipoprotein (a) and Cardiovascular Risk: The Show Must go on. | 2017 | Details |
| A16948 | 28077863 | Int J Obes (Lond) | What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? | 2017 | Details |
| A16949 | 28077733 | J Nutr | Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens. | 2017 | Details |
| A16950 | 28077318 | Exp Mol Pathol | Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. | 2017 | Details |
| A16952 | 28076482 | Arq Bras Cir Dig | CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY. | 2017 | Details |
| A16971 | 28069746 | Postgrad Med J | Non-alcoholic fatty pancreas disease. | 2017 | Details |
| A16975 | 28067590 | Biosci Biotechnol Biochem | BCL11B gene heterozygosity causes weight loss accompanied by increased energy consumption, but not defective adipogenesis, in mice. | 2017 | Details |
| A16980 | 28064372 | Obes Surg | Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction. | 2017 | Details |
| A16993 | 28058076 | Gastroenterology Res | Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. | 2016 | Details |
| A16996 | 28053786 | Int J Hepatol | Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17009 | 28051792 | Ann Hepatol | Management strategies for liver fibrosis. | 2017 | Details |
| A17013 | 28050048 | Am J Gastroenterol | Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes? | 2017 | Details |
| A17020 | 28040302 | Clin Nutr | Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials. | 2016 | Details |
| A17022 | 28039158 | Am J Physiol Gastrointest Liver Physiol | Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. | 2016 | Details |
| A17023 | 28039099 | J Hepatol | Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. | 2016 | Details |
| A17024 | 28038998 | Toxicol Appl Pharmacol | Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice. | 2016 | Details |
| A17026 | 33442082 | J ASEAN Fed Endocr Soc | Diabetes Mellitus and Prediabetes in Patients with Hepatocellular Carcinoma in a Tertiary Philippine Hospital. | 2017 | Details |
| A17027 | 31509653 | Klin Lab Diagn | [The cognitive biological function, difference in etiology and generality of pathogenesis of metabolic pandemics. The metabolism regulation in carnivorous and herbivorous animals under effect of environment factors.] | 2017 | Details |
| A17028 | 30802390 | Klin Lab Diagn | [The phylogenetic theory of general pathology. The development of seven biological functions, seven specific ones and etiological factors of metabolic epidemics, millions years' common pathogenesis and basics of prevention.] | 2019 | Details |
| A17038 | 28036028 | Nutrients | Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice. | 2016 | Details |
| A17040 | 28035202 | Gastroenterol Hepatol (N Y) | Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials. | 2016 | Details |
| A17041 | 28034722 | Brain Res | Specific regions of the brain are capable of fructose metabolism. | 2016 | Details |
| A17044 | 28032449 | Diabetes Metab Res Rev | Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A17045 | 28030556 | PLoS One | Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17046 | 28030540 | PLoS One | Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor. | 2016 | Details |
| A17047 | 28029021 | Endocrinol Metab (Seoul) | Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17048 | 28028821 | Aliment Pharmacol Ther | Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17054 | 28025996 | Int J Mol Med | Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17055 | 28025059 | J Hepatol | MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. | 2016 | Details |
| A17058 | 28017785 | Mol Cell Endocrinol | Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. | 2016 | Details |
| A17061 | 28013023 | Semin Cell Dev Biol | Metabolic roles of poly(ADP-ribose) polymerases. | 2016 | Details |
| A17067 | 28011892 | Gut | Adipose type I interferon signalling protects against metabolic dysfunction. | 2016 | Details |
| A17070 | 28008992 | Sci Rep | Acylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats. | 2016 | Details |
| A17073 | 28007783 | FASEB J | Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. | 2016 | Details |
| A17074 | 28007354 | Sleep Med | Gut epithelial barrier markers in patients with obstructive sleep apnea. | 2016 | Details |
| A17075 | 28006772 | Cell Physiol Biochem | Involvement of Sphingosine 1-Phosphate in Palmitate-Induced Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17078 | 28003715 | J Clin Exp Hepatol | High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice. | 2016 | Details |
| A17081 | 28001263 | Rev Assoc Med Bras (1992) | Current management of non-alcoholic fatty liver disease. | 2016 | Details |
| A17083 | 27999887 | Abdom Radiol (NY) | Imaging patterns and focal lesions in fatty liver: a pictorial review. | 2017 | Details |
| A17085 | 27999564 | Front Endocrinol (Lausanne) | Distinct Hepatic Macrophage Populations in Lean and Obese Mice. | 2016 | Details |
| A17086 | 27999105 | Diabetes | Hepatic DPP4 DNA Methylation Associates With Fatty Liver. | 2016 | Details |
| A17089 | 27997977 | Semin Liver Dis | Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin. | 2016 | Details |
| A17090 | 27997970 | Semin Liver Dis | The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome. | 2016 | Details |
| A17099 | 27992443 | PLoS One | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. | 2016 | Details |
| A17100 | 27992361 | J Pediatr Endocrinol Metab | Risk factors that affect metabolic health status in obese children. | 2017 | Details |
| A17103 | 27990792 | Minerva Endocrinol | Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne. | 2016 | Details |
| A17104 | 27989689 | Clin Res Hepatol Gastroenterol | CD40 signaling and hepatic steatosis: Unanticipated links. | 2016 | Details |
| A17105 | 27989517 | Diabetes Metab Syndr | Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S. | 2016 | Details |
| A17110 | 27986627 | Eur J Pharmacol | A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. | 2016 | Details |
| A17111 | 27986466 | Trends Endocrinol Metab | Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies. | 2016 | Details |
| A17115 | 27984419 | J Dev Behav Pediatr | Family Functioning Predicts Body Mass Index and Biochemical Levels of Youths with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A17120 | 27981809 | Mol Nutr Food Res | Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. | 2017 | Details |
| A17123 | 27980597 | Nutr Metab (Lond) | Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. | 2016 | Details |